RecruitingNCT07184619
Evenamide added to usual care for treatment-resistant schizophrenia
About this title
Read the official source — NCT07184619Medication studyAges 18+Multiple countries
Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
You are randomly assigned to evenamide 15 mg twice daily or matching placebo (an inactive comparison treatment), alongside your current stable treatment. The add-on treatment period lasts 12 weeks.
- Listed locations
- Los Angeles and 18 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Participation duration
- The add-on treatment lasts 12 weeks.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 23, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 400
- Sponsor
- Newron Pharmaceuticals SPA
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Argentina, India, ...
- Age range
- Over 18 Years
- Official registry ID
- NCT07184619
- Official title
Show the full official title
A Phase III, 12-week, Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Determine the Efficacy, Safety, and Tolerability of a Dose of 15 mg Bid of Evenamide as add-on in Patients With Documented Treatment-resistant Schizophrenia, Which is Not Adequately Controlled by a Stable Therapeutic Dose of the Patient's Current Antipsychotic Medication(s)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Los Angeles, United States · Miami, United States · Atlanta, United States
16 more locations
- Baltimore, United States
- New York, United States
- Buenos Aires, Argentina
- Vijayawada, India
- Guwahati, India
- Mumbai, India
- Nagpur, India
- Navi Mumbai, India
- Madurai, India
- Bībīnagar, India
- Lucknow, India
- Kolkata, India
- Kuala Lumpur, Malaysia
- Kangar, Malaysia
- Kuching, Malaysia
- Sungai Petani, Malaysia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Newron Pharmaceuticals SPA.
Does this study involve medication?
Yes. The study involves medication, including Evenamide 15 mg bid and Placebo.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
